华虹(01347.HK)及中芯(00981.HK)随美及A股同业续弹逾4%-5%
美国费城半导体指数承上周五(24日)弹2.3%,昨晚再升1.3%收1,725,创逾一个月高。此外,内地半导体及国产芯片板块今早逆沪指急涨2.5%。
本港中芯(00981.HK)及华虹半导体(01347.HK)连弹第二天,今早反覆高见14.82元及14.86元,现造14.78元及14.8元,续弹5.1%及4.1%,前者重越10天线(14.71元),後者挑战20天线(14.82元),成交分别为2,815万股及208万股。
港股於期结日反覆续升117点或0.5%,报24,397,成交额仅370亿元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.